Andrew Reisner
This speaker appears at this event:

This speaker’s events are being finalized

Andrew Reisner, MD

  • Director, Clinical Decision Technology Laboratory, MGH
  • Associate Professor, Emergency Medicine, HMS

Andrew Reisner, MD is an Associate Professor at Harvard Medical School (HMS) in the Department of Emergency Medicine and serves as the director of the Massachusetts General Hospital (MGH) Clinical Decision Technology Laboratory (CDTL). Dr. Reisner studied undergraduate engineering at Stanford University and received his medical degree from HMS. Early professional experience included years as a research scientist at the Massachusetts Institute of Technology, working on the development of MIMIC-2, the world’s largest publicly-available ICU research database. He also had a long-standing research appointment with the US Army developing AI-based diagnostics; for that work, the research team was awarded the Heyman Service to America Medal. For a decade, Dr. Reisner was the physician leader for the MGH Emergency Department’s clinical informatics system.

Founded and led by Dr. Reisner, the MGH CDTL has been granted over $5M in competitive funding. The CTDL develops and deploys automated software systems to enable care that is safer, more efficient, and more effective. Its scope of work has spanned computational techniques –accommodating data fluctuations through time; measurement artifact; multi-parameter analysis; and machine learning – methodological issues – how to build, curate, and effectively analyze large electronic databases; how to design user interfaces and implement software systems that allow for effective real-time clinician interactions – and clinical investigations – assessing novel technologies during actual clinical operations, and whether investigational technology offers additional benefit over routine care. Dr. Reisner has been an invited speaker, advisor, or collaborator with companies including General Electric, Philips, Nihon Kohden, Massimo, Zoll, Sotera, FitBit, and Google.

Covid-19 Broadcast
May 11, 2020
Live Event
May 10–12, 2021